Department of Internal Medicine, Botucatu Medical School, Sao Paulo State University (UNESP), Botucatu, Brazil.
Department of Applied Physical Therapy, Federal University of Triângulo Mineiro (UFTM), Uberaba, Brazil.
J Stroke Cerebrovasc Dis. 2022 Dec;31(12):106837. doi: 10.1016/j.jstrokecerebrovasdis.2022.106837. Epub 2022 Oct 22.
We aimed to evaluate the predictive performance of the PRISMA-7 frailty criteria regarding the composite outcome of disability or death in patients with an acute ischemic stroke, and to compare it with the Frailty Index and the National Institutes of Health Stroke Scale (NIHSS).
This prospective cohort study involved all patients aged ≥ 40 years admitted with an acute ischemic stroke between March 2019 and January 2020. We performed survival analyses, calculated risk ratios, sensitivity, specificity, and predictive values for the combined outcome of disability or death according to the presence of frailty as determined by the PRISMA-7 and the Frailty Index, and stroke severity based on the NIHSS.
In 174 patients with acute ischemic stroke, being frail in the week before the stroke according to the PRISMA-7 was associated with a Risk Ratio of 4·50 (95%CI 1·77-11·43, P <0·001) and a Positive Predictive Value of 89% (95%CI 77-99%) for being disabled or dead 90 days after the stroke, and a Hazard Ratio of 3·33 (95%CI 1·48-7·51, P = 0·004) for the survival outcome. The predictive performance of the PRISMA-7 was not significantly different from the Frailty Index or the NIHSS.
We provide evidence that the PRISMA-7 frailty criteria may be a useful prognostication tool in acute ischemic stroke.
我们旨在评估 PRISMA-7 衰弱标准对伴有急性缺血性脑卒中的残疾或死亡复合结局的预测性能,并将其与衰弱指数和美国国立卫生研究院卒中量表(NIHSS)进行比较。
这是一项前瞻性队列研究,纳入了 2019 年 3 月至 2020 年 1 月期间因急性缺血性脑卒中入院的所有年龄≥40 岁的患者。我们进行了生存分析,计算了残疾或死亡复合结局的风险比、灵敏度、特异度和预测值,根据 PRISMA-7 和衰弱指数确定的衰弱状态以及根据 NIHSS 确定的卒中严重程度进行分组。
在 174 例急性缺血性脑卒中患者中,根据 PRISMA-7 在卒中前一周被判定为衰弱与风险比 4.50(95%CI 1.77-11.43,P<0.001)和 90 天后残疾或死亡的阳性预测值 89%(95%CI 77-99%)相关,并且与生存结局的风险比 3.33(95%CI 1.48-7.51,P=0.004)相关。PRISMA-7 的预测性能与衰弱指数或 NIHSS 无显著差异。
我们提供了证据表明,PRISMA-7 衰弱标准可能是急性缺血性脑卒中的一种有用的预后工具。